Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Banc of California Inc is a banks-regional business based in the US. Banc of California shares (BANC) are listed on the NYSE and all prices are listed in US Dollars. Banc of California employs 600 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$19.09|
|52-week range||$10.83 - $21.26|
|50-day moving average||$18.42|
|200-day moving average||$17.83|
|Wall St. target price||$21.38|
|Dividend yield||$0.24 (1.22%)|
|Earnings per share (TTM)||$1.10|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||0.21%|
|1 month (2021-09-22)||6.83%|
|3 months (2021-07-22)||12.69%|
|6 months (2021-04-22)||10.60%|
|1 year (2020-10-21)||67.16%|
|2 years (2019-10-21)||27.10%|
|3 years (2018-10-19)||8.59%|
|5 years (2016-10-21)||44.18%|
Valuing Banc of California stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Banc of California's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Banc of California's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Banc of California shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Banc of California's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.15. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Banc of California's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$255.1 million|
|Operating margin TTM||37.38%|
|Gross profit TTM||$213.8 million|
|Return on assets TTM||0.9%|
|Return on equity TTM||8.48%|
|Market capitalisation||$967.6 million|
TTM: trailing 12 months
There are currently 2.2 million Banc of California shares held short by investors – that's known as Banc of California's "short interest". This figure is 6.2% down from 2.4 million last month.
There are a few different ways that this level of interest in shorting Banc of California shares can be evaluated.
Banc of California's "short interest ratio" (SIR) is the quantity of Banc of California shares currently shorted divided by the average quantity of Banc of California shares traded daily (recently around 220181.57370518). Banc of California's SIR currently stands at 10.04. In other words for every 100,000 Banc of California shares traded daily on the market, roughly 10040 shares are currently held short.
However Banc of California's short interest can also be evaluated against the total number of Banc of California shares, or, against the total number of tradable Banc of California shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Banc of California's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Banc of California shares in existence, roughly 40 shares are currently held short) or 0.0479% of the tradable shares (for every 100,000 tradable Banc of California shares, roughly 48 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Banc of California.
Find out more about how you can short Banc of California stock.
Dividend payout ratio: 22.22% of net profits
Recently Banc of California has paid out, on average, around 22.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Banc of California shareholders could enjoy a 1.26% return on their shares, in the form of dividend payments. In Banc of California's case, that would currently equate to about $0.24 per share.
While Banc of California's payout ratio might seem low, this can signify that Banc of California is investing more in its future growth.
Banc of California's most recent dividend payout was on 30 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 September 2021 (the "ex-dividend date").
Over the last 12 months, Banc of California's shares have ranged in value from as little as $10.83 up to $21.2564. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Banc of California's is 1.7127. This would suggest that Banc of California's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Banc of California, Inc. operates as the bank holding company for Banc of California, National Association that provides banking products and services in the United States. The company offers deposit products, including checking, savings, money market, retirement, and interest-bearing and noninterest-bearing demand accounts, as well as certificate of deposits. It also provides various commercial and consumer loan products, such as commercial and industrial loans; commercial real estate and multifamily loans; construction loans; single family residential mortgage loans; warehouse and indirect/direct leveraged lending; home equity lines of credit; small business administration loans; and other consumer loans. In addition, the company offers automated bill payment, cash and treasury management, foreign exchange, card payment, remote and mobile deposit capture, automated clearing house origination, wire transfer, direct deposit, and internet banking services; and master demand accounts, interest rate swaps, and safe deposit boxes. Further, it invests in collateralized loan obligations, agency securities, municipal bonds, agency residential mortgage-backed securities, and corporate debt securities. As of December 31, 2020, the company operated 29 full-service branches in Southern California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.